The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world survival outcomes associated with use of pertuzumab and trastuzumab emtansine (T-DM1) for HER2-positive (HER2+) metastatic breast cancer (MBC) in Brazilian private healthcare setting.
 
Rodrigo Dienstmann
Employment - Oncoclínicas
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Speakers' Bureau - Amgen; Ipsen; Libbs; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Merck
 
Heloisa Cruz
No Relationships to Disclose
 
Aline Coelho Gonçalves
No Relationships to Disclose
 
Diocesio Alves Pinto de Andrade
No Relationships to Disclose
 
Pedro Emanuel Rubini Liedke
No Relationships to Disclose
 
Rafael Brant Costa
No Relationships to Disclose
 
Mario Alberto Dantas Loures da Costa
No Relationships to Disclose
 
Alexandre Boukai
Consulting or Advisory Role - Genomic Health
 
Flavia Rocha Paes
No Relationships to Disclose
 
Luciana G. Landeiro
Consulting or Advisory Role - GlaxoSmithKline
 
Daniel Luiz Gimenes
No Relationships to Disclose
 
Maria Cristina Figueroa Magalhaes
No Relationships to Disclose
 
Cristiano Augusto Andrade de Resende
Honoraria - BMS Brazil; Daiichi Sankyo/Astra Zeneca; MSD Oncology; Novartis; Pfizer; Roche
 
Tomas Reinert
Honoraria - AstraZeneca; Libbs; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Lilly; Novartis
Research Funding - AstraZeneca (Inst); Libbs (Inst)
 
Pedro N. Aguiar Junior
Stock and Other Ownership Interests - Blau Farmaceutica
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Merck; SERVIER
Consulting or Advisory Role - Amgen
 
Rafael Paes
Speakers' Bureau - MSD Oncology
 
Matheus Costa e Silva
Employment - Grupo Oncoclínicas; Rede D'Or São Luiz
 
Bruno Lemos Ferrari
No Relationships to Disclose
 
Max S. Mano
Employment - Grupo Oncoclinicas
Stock and Other Ownership Interests - Fleury Group; Hypera Pharma
Honoraria - DASA; Grupo Fleury; Lilly/ImClone; MSD Oncology; Novartis; Oncologia Brasil; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Lilly/ImClone; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
(OPTIONAL) Uncompensated Relationships - Roche